當(dāng)前位置：   首頁 > 需求大廳

 >  特色服務(wù) 

 >  信息服務(wù) 

1、Effect of probenecid or diet on tebipenem pivoxil tablets pharmacokinetics in healthy male volunteers； 2、Effect of diet on the pharmacokinetics of tebipenem pivoxil fine granules in healthy male volunteers； 3、Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infection 1、Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects. Jin C, Jeon JY, Im YJ, Jeong JA, Kim Y, Chae SW, Bentz J, Kumke T, Kim MG. 7.The control of myopia with atropine.   [更多]

根據(jù)已知省份、城市的醫(yī)院銷售數(shù)據(jù)樣本，根據(jù)樣本數(shù)據(jù)如何計(jì)算醫(yī)院銷售數(shù)據(jù)在全國的銷售量、銷售額？ 放大規(guī)則提供相關(guān)原理，思路，計(jì)算中所需要的樣本變量（字段，如：如“某藥品的藥品銷售額”與“樣本對于省份”，“樣本城市數(shù)量”、“樣本醫(yī)院數(shù)量”、“樣本醫(yī)院等級比例”等的關(guān)系），以及相關(guān)規(guī)格參數(shù)以及參數(shù)計(jì)算的方式，具體細(xì)節(jié)可私下溝通。   [更多]

1、American Conference of Governmental Industrial Hygienists TLVs and BEIs. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH, 2008, 2、內(nèi)容：Totsuka K，F(xiàn)urukawa M，F(xiàn)uruya N，et al. PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial （3）.45th Intersci Conf Antimicrob Agents Chemother（ICAAC）（Dec 16-19. Washington，D.C.），2005，Abst L-579標(biāo)題 PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial； 3、PK–PD analysis of tebipenem pivoxil in clinical trials for pediatric patients. Jpn J Chemother. 2009;57(S-1):186–91. 4、Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system. González MA1, Straughan AB. 5、Single dose study of the bioequivalence of two sustained-release theophylline formulations. Contreras J, Pérez N, González R, Ontivero E, López M. Arzneimittelforschung. 1998 Mar;48(3):259-62. 6、National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information., AD277-689 7、Graul, A.; Castaner, J.; Atorvastatin Calcium. Drugs Fut 1997, 22, 9, 956. 8、Formulation And Evaluation of Topical Aceclofenac Gel Using Different Gelling Agent（JAPAN PATEL1*, BRIJESH PATEL1, HARDEEPSINGH BANWAIT1, KAUSHAL PARMAR1,MANISH PATEL2 Department of Pharmaceutics, Sat Kaival College of Pharmacy, Sarsa, Anand, Gujarat, India Nootan Pharmacy College, Visnagar, Gujarat, India） 9、NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996 Dec;10(12):1813-22 10、Preliminary studies on toxic effects of some vulcanizing accelerators 11、Dose Dumping Dose dumping is an increased concern with drugs manufactured as modified-release (MR) formulations, that is, where drug   [更多]

1、托伐普坦治療ADPKD臨床實(shí)踐指南解讀 2、Severino B, Luisi G, Donomae Iwamoto R, Moreno RA, Perez Teixeira V, Di Vaio P, Saccone I, Magli E, Santagada V, Caliendo G, Mendes GD, De Nucci G. 3、Executive?summary?on?acetaminophen?efficacy?and?safety.?McNeil?Consumer?&?SpecialtyPharmaceuticals.?Data?on?file.?2002-9-19.?Nonprescription?Drugs?Advisory?Committee?Meeting?2002?8?20 4、Polymorphism and pseudopolymorphism on nifedipine 5、Ullmann, vol.18, p.223 1979年的文獻(xiàn) 6、Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey   [更多]

上海市計(jì)生所需要一份醋酸戈舍瑞林緩釋植入劑的信息   [更多]

1.Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone. 2、Supermini NLP (SMP): Material, indicaciones, técnica, ventajas y resultados. 3、A new formulation of etomidate in lipid emulsion--bioavailability and venous provocation 4、Etomidate using a new solubilizer. Experimental clinical studies on venous tolerance and bioavailability 5、中國急性冠狀動脈綜合征防治現(xiàn)狀藍(lán)皮書2015   [更多]

1、Klin Anasthesiol Intensivther. 1993;44:3-10; discussion 108-13.[Pharmacodynamics and pharmacokinetics of the newer intravenous anesthetics (etomidate, propofol, S-ketamine)]. 2、Eur J Anaesthesiol. 1985 Jun;2(2):133-42. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example. Schüttler J, Schwilden H, Stoeckel H. 3、Responses of Total and Bioavailable 25-Hydroxyvitamin D and Factors Modifying the Responses: A Randomized, Placebo-Controlled Trial of Vitamin D3 Supplementation in an Asian Population 4、Preventative Approaches for Neuropathy in Diabetes with Alpha-lipoic Acid (PANDA Study) 5、Indacaterol/mometasone - Novartis Alternative Names: Mometasone furoate/indacaterol acetate; Mometasone/indacaterol; QMF-149 Latest Information Update: 13 Sep 2019   [更多]

EP10.0: 1. 昔萘酸沙美特羅Salmeterol Xinafoate 2. 對氨基水楊酸鈉Sodium Aminosalicylate Dihydrate 3. 亞胺培南Imipenem monohydrate 4. 西司他丁鈉Cilastatin sodium 5. 制霉菌素Nystatin 6. ω-3 脂肪酸甘油三酯Omega-3-Acid Triglycerides 7. 噻托溴銨一水合物Tiotropium Bromide Monohydrate 8. 硫酸沙丁胺醇Sulbutamol Sulphate 文獻(xiàn)： 1、Preventative approaches for neurophathy in diabetes with Alpha-lipoic Acid 2奧硝哩 在人體 內(nèi)的代謝與排泄研究 杜江 波 ” , 尤 天庚 ’ , 陳笑艷 ’ , 鐘 大放 ” 1. 中國科學(xué)院上海藥物研究所 , 上海 2 0 1 2 03 2 . 上海東方醫(yī)院 , 上海 2 0 01 2 0   [更多]

1、Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor 【出處】Vutreshni bolesti. 2000;32(1):33-6. 2、Bioequivalence study between two slow release batches ofindapamide SR 1.5 mg with different dissolution pro- files after repeated oral administration over 7 days in 12 healthy volunteers: a randomised double blind cross over study. Fulmer Hall, UK: Servier, 1993. Report No.: NP 910 3、Schiavi P, Jochemsen R, Hiley M, et al. Pharmacokinetics ofslow and immediate release formulations of indapamide after single oral administration under fasting conditions and after food, in healthy volunteers. Eur J Drug Metab Pharmacokinet 1996; Spe- cial Issue: 42 4、找一篇97年的政策法規(guī)文件，標(biāo)題：國家醫(yī)藥管理局國藥字（97）253號文件 5、Higuchi T, Murasaki M, Kamijima K. Clinical evaluation of duloxetine in the treatment of major depressive disorder. Jpn J Clin Psychopharmacol 2009;12:1613-1634   [更多]

1、targeting inhaled steroids 文獻(xiàn) 2、Minerva Dietol Gastroenterol. 1989 Jul-Sep;35(3):175-89. [A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties]. [Article in Italian] Del Tacca M, Danesi R, Blandizzi C, Bernardini MC. 3、See 1 citation found by title matching your search: J Pharmacol. 1985;16 Suppl 2:145-69. [MI cholinergic receptors of gastric secretion: current status]. [Article in French]、 4、Carrigan PJ, Papp K, Schulz G, Venable T. Bioavailability of valproate from divalproex sodium tablets. Abbott Laboratories, North Chicago, IL (unpublished data). 5、MITOXANTRONE - MECHANISM OF ACTION, ANTITUMOR-ACTIVITY, PHARMACOKINETICS, EFFICACY IN THE TREATMENT OF SOLID TUMORS AND LYMPHOMAS, AND TOXICITY，文獻(xiàn) 6、American Journal of Kidney Diseases Volume 70, Issue 6, December 2017, Pages 737-751 KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)   [更多]